Best Payload Podcasts (2024)

1
Chairperson Perspective: Precision Payloads: Exploring ADC-Directed Therapies in HER2-Mutant and Overexpressing Lung Cancer

18h ago

—

CME credits: 0.50 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/chairperson-perspective-precision-payloads-exploring-adc-directed-therapies-in-her2-mutant-and-overexpressing-lung-cancer/16609/ Alterations in ERBB2, the gene encoding HER2, have been recognized as drivers in the development of NSCLC. Therefore, HER…

1
How to Use Prognostic Risk Scoring and Symptom Burden Assessment to Tailor Myelofibrosis Treatment

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-to-use-prognostic-risk-scoring-and-symptom-burden-assessment-to-tailor-myelofibrosis-treatment/26504/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particu…

1
Pacritinib for Myelofibrosis Across the Cytopenic Spectrum

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pacritinib-for-myelofibrosis-across-the-cytopenic-spectrum/26507/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can s…

1
Case Discussion: What JAK Inhibitor Should I Use in a Transfusion-Dependent Patient With MF With Platelets > 50 × 109/L?

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-discussion-what-jak-inhibitor-should-i-use-in-a-transfusion-dependent-patient-with-mf-with-platelets-50-109l/26512/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhi…

1
Improving Transfusion Independence With JAK Inhibitor Therapy

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-transfusion-independence-with-jak-inhibitor-therapy/26509/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, ca…

1
Managing Treatment-Related Toxicities With JAK Inhibitor Therapy in Myelofibrosis

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-treatment-related-toxicities-with-jak-inhibitor-therapy-in-myelofibrosis/26511/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopen…

1
Managing Myelofibrosis-Associated Anemia

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-myelofibrosis-associated-anemia/26508/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly impro…

1
How and When to Manage Ruxolitinib Failure

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/how-and-when-to-manage-ruxolitinib-failure/26505/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significantly imp…

1
Managing Myelofibrosis-Associated Thrombocytopenia

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-myelofibrosis-associated-thrombocytopenia/26510/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic myelofibrosis, can significa…

1
Treatment Options for Ruxolitinib Intolerance or Resistance in Myelofibrosis

18h ago

—

CME credits: 1.00 Valid until: 19-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/treatment-options-for-ruxolitinib-intolerance-or-resistance-in-myelofibrosis/26506/ Primary myelofibrosis is a complex disease requiring precise treatment strategies. Effective selection and sequencing of JAK inhibitors, particularly for cytopenic my…

1
Episode 80: Pwn2Own VS H1 Live Hacking Event (feat SinSinology) 2:49:26

28m ago2:49:26

2:49:26

Episode 80: In this episode of Critical Thinking - Bug Bounty Podcast Justin is joined by Sina Kheirkhah to talk about the start of his hacking journey and explore the differences between the Pwn2Own and HackerOne Events Follow us on twitter at: @ctbbpodcast We're new to this podcasting thing, so feel free to send us any feedback here: info@critica…

1
Advancements in GU Cancers: Key Data from AUA 2024

15h ago

—

CME credits: 0.50 Valid until: 18-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/advancements-in-gu-cancers-key-data-from-aua-2024/24417/ Despite treatment advances in genitourinary cancers, most patients will develop relapsed disease. Thus, new treatment approaches are needed, as well as improved methods to identify patients who…

1
Empowering Treatment Choice: The Essential Role of Shared Decision-Making in Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/empowering-treatment-choice-the-essential-role-of-shared-decision-making-in-unresectable-hcc/26338/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinati…

1
Selecting the Optimal ICI Partner for First-Line Treatment of Unresectable HCC: CTLA-4 vs VEGF Inhibitors

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/selecting-the-optimal-ici-partner-for-first-line-treatment-of-unresectable-hcc-ctla-4-vs-vegf-inhibitors/26332/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (IC…

1
Use of ICI Combination Regimens in Patients With Intermediate-Stage HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/use-of-ici-combination-regimens-in-patients-with-intermediate-stage-hcc/26333/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment…

1
Current Unmet Needs in the Field of Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/current-unmet-needs-in-the-field-of-unresectable-hcc/26329/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the treatment of unresectable he…

1
Managing Adverse Events Associated With ICI Combinations in Patients With Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/managing-adverse-events-associated-with-ici-combinations-in-patients-with-unresectable-hcc/26336/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combination…

1
Pivotal Data Supporting First-Line Durvalumab/Tremelimumab in Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pivotal-data-supporting-first-line-durvalumabtremelimumab-in-unresectable-hcc/26330/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tre…

1
Case by Case: Optimizing Dual Immune Checkpoint Inhibitor Combination Therapies in Advanced Driver-Negative Non–Small Cell Lung Cancer

17h ago

—

CME credits: 1.50 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-by-case-optimizing-dual-immune-checkpoint-inhibitor-combination-therapies-in-advanced-driver-negative-nonsmall-cell-lung-cancer/24418/ Struggling to navigate the latest immunotherapy options for advanced NSCLC? This online CME program delves int…

1
Case Consult: Treatment Options for an Unresectable HCC Patient Who Has Esophageal Varices

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-options-for-an-unresectable-hcc-patient-who-has-esophageal-varices/26335/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations…

1
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/emerging-first-line-ici-combination-regimens-in-patients-with-unresectable-hcc/26334/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tr…

1
Enhancing Outcomes in Unresectable HCC Through Integrated Multidisciplinary Care Models

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/enhancing-outcomes-in-unresectable-hcc-through-integrated-multidisciplinary-care-models/26337/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations f…

1
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC

17h ago

—

CME credits: 1.00 Valid until: 17-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/pivotal-data-supporting-first-line-atezolizumabbevacizumab-in-unresectable-hcc/26331/ This online MinuteCE program provides a comprehensive evaluation of the latest clinical data on first-line immune checkpoint inhibitor (ICI) combinations for the tr…

1
Optimizing Biomarker Testing to Guide Treatment Selection for Metastatic Colorectal Cancer

23h ago

—

CME credits: 1.00 Valid until: 16-11-2024 Claim your CME credit at https://reachmd.com/programs/project-oncology/program-name/26365/ This 1.0-credit activity provides oncology clinicians with practical insights into the importance of biomarker testing in patients diagnosed with metastatic colorectal cancer (mCRC), optimizing biomarker testing proce…

1
Grand Design, with Ian Cinnamon (Apex) 58:04

5h ago58:04

58:04

Fresh off of a $95M Series B funding round, this week we bring back Ian Cinnamon, CEO of Apex, on to the show. Ian, along with his co-founder Max Benassi, started Apex to address the bottleneck in satellite bus manufacturing. Apex is revolutionizing the small satellite bus market with its productized approach and rapid manufacturing capabilities. O…

1
Episode 79: The State of CSS Injection - Leaking Text Nodes & HTML Attributes 1:10:25

2d ago1:10:25

1:10:25

Episode 79: In this episode of Critical Thinking - Bug Bounty Podcast we deepdive CSS injection, and explore topics like sequential import chaining, font ligatures, and attribute exfiltration. Follow us on twitter at: @ctbbpodcast Send us any feedback here: info@criticalthinkingpodcast.io Shoutout to YTCracker for the awesome intro music! ------ Li…

1
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

3d ago

—

CME credits: 1.00 Valid until: 10-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/spinal-muscular-atrophy-optimizing-the-management-of-adults-in-the-era-of-disease-modifying-therapies/26352/ Explore this on-demand webcast for an in-depth expert presentation and case discussion. This educational initiative is designed to help neuro…

1
Space Market Realities, with Pierre Lionnet (Eurospace) 1:08:41

4d ago1:08:41

1:08:41

There aren’t many dedicated space economists out there, but today we’re lucky enough to be joined by one. This week’s Pathfinder guest is Pierre Lionnet, Research and Managing Director at Eurospace, who shares his critical and thought-provoking insights into the space economy. Pierre, with a background in engineering and finance, has spent 30 years…

1
Episode 78: Less Writing, More Hacking - Reporting Efficiency Techniques 1:06:25

14d ago1:06:25

1:06:25

Episode 78: In this episode of Critical Thinking - Bug Bounty Podcast we’re talking about writing reports. We share some tips that we’ve learned, and discuss ways that AI can (and can’t) help with that process. We also talk about the benefit of using tools like Fabric, Loom, and ShareX. Follow us on twitter at: @ctbbpodcast We're new to this podcas…

1
Agent to Investor, with Mike Palank (MaC Venture Capital) 1:04:21

11d ago1:04:21

1:04:21

It’s not every day you get to hear space industry perspectives from a former Hollywood talent agent turned investor. Today we're joined by Mike Palank, General Partner at MaC Venture Capital, who shares his career path and insights into the world of VC. Mike, with a background in the entertainment industry, including working at WME as a talent agen…

1
Multiple Myeloma Care: Translating Evolving Practices to Oncology Nurses in Community Settings

11d ago

—

CME credits: 1.00 Valid until: 02-07-2025 Claim your CME credit at https://reachmd.com/programs/cme/multiple-myeloma-care-translating-evolving-practices-to-oncology-nurses-in-community-settings/24150/ The expansion of treatment options and strategies across the disease continuum is good news for patients who previously had few options; however, it …

1
State Privacy Laws: A Conversation with Oregon & Texas Regulators about Privacy Enforcement 30:05

15d ago30:05

30:05

In this episode of the Wiley Connected podcast, hosts Duane Pozza and Kat Scott, partners in Wiley's Privacy, Cyber, and Data Governance practice, discuss the implications of new comprehensive privacy laws in Oregon and Texas effective July 1, 2024. They are joined by Tyler Bridegan from the Texas Attorney General's Office and Kristen Hilton from t…

1
Episode 77: Bug Bounty Mental - Practical Tips for Staying Sharp & Motivated 1:50:26

19d ago1:50:26

1:50:26

Episode 77: In this episode of Critical Thinking - Bug Bounty Podcast Joel and Justin discuss some fresh writeups including some MongoDB injections, ORMs, and exploits in Kakao and iOS before pivoting into a conversation about staying motivated and avoiding burnout while hunting. Follow us on twitter at: @ctbbpodcast We're new to this podcasting th…

1
Episode 76: Match & Replace - HTTP Proxies' Most Underrated Feature 1:34:43

23d ago1:34:43

1:34:43

Episode 76: In this episode of Critical Thinking - Bug Bounty Podcast we’re talking about Match and Replace and the often overlooked use cases for it, like bypassing paywalls, modifying host headers, and storing payloads. We also talk about the HackerOne Ambassador World Cup and the issues with dupe submissions, and go through some write-ups. Follo…

1
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago

1M ago

—

CME credits: 1.25 Valid until: 05-02-2025 Claim your CME credit at https://reachmd.com/programs/cme/practice-changing-highlights-in-ggej-cancers-the-latest-data-from-chicago/26438/ The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence su…

1
A View From Above, with Mason Angel (Industrious Ventures) 45:06

26d ago45:06

45:06

Ever wanted to hear the firsthand experience of a New Shepard astronaut? Well, today we're joined by Mason Angel, General Partner at Industrious Ventures, who was on Blue Origin’s most recent flight to space. Mason, with a background deeply rooted in industrial sectors like GE and Linde through his family, shares his unique journey and insights int…

1
Episode 75: Rerun of The OG Bug Bounty King - Frans Rosen 2:44:52

1M ago2:44:52

2:44:52

Episode 75: In this episode of Critical Thinking - Bug Bounty Podcast, Justin and Joel are sick, So instead of a new full episode, we're going back 30 episodes to review. Follow us on twitter at: @ctbbpodcast We're new to this podcasting thing, so feel free to send us any feedback here: info@criticalthinkingpodcast.io Shoutout to YTCracker for the …

1
The Blue Ghost, with Ray Allensworth (Firefly) 47:50

1M ago47:50

47:50

This week on Pathfinder, we're joined by Ray Allensworth, Spacecraft Program Director at Firefly Aerospace. Ray, who has a previous background with major aerospace names like Raytheon and Northrop, helps lead Blue Ghost, Firefly’s lunar lander program designed to deliver scientific and commercial payloads to the surface of the Moon. The company is …

1
Improving Adherence and Persistence With Durable Anti-VEGF Therapies for nAMD

2M ago

—

CME credits: 0.25 Valid until: 07-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/improving-adherence-and-persistence-with-durable-anti-vegf-therapies-for-namd/18068/ This case consult with Dr Do and Dr Kaiser will consider a treatment-experienced patient referred for a 2nd opinion with decreased vision and prior diagnosis of neov…

1
Episode 74: Supply Chain Attack Primer - Popping RCE Without an HTTP Request (feat 0xLupin) 1:38:20

1M ago1:38:20

1:38:20

Episode 74: In this episode of Critical Thinking - Bug Bounty Podcast Justin sits down with Roni "Lupin" Carta for a deep dive into supply chain attacks and dependency confusion. We explore the supply chain attacks, the ethical considerations surrounding maintainers and hosting packages on public registries, and chat about the vision and uses of hi…

1
Free-Flying Stations, with Jed McCaleb & Max Haot (Vast) 58:57

2M ago58:57

58:57

This week on Pathfinder, we're joined by Jed McCaleb, Founder, and Max Haot, CEO, the leaders behind Vast, a company pioneering the development of commercial space stations. Jed, a seasoned software entrepreneur, and Max, a veteran in space and internet ventures, bring their unique expertise to the ambitious goal of advancing human habitation in sp…

1
CD20 X CD3 Bispecifics—Redefining Treatment for Patients with R/R DLBCL/LBCL in the Community Setting

2M ago

—

CME credits: 0.50 Valid until: 30-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/cd20-x-cd3-bispecificsredefining-treatment-for-patients-with-rr-dlbcllbcl-in-the-community-setting/17877/ In the rapidly evolving landscape of treating patients with relapsed or refractory large/diffuse large B-cell lymphoma (R/R LBCL/DLBCL), recent …

1
Episode 73: Sandboxed IFrames and WAF Bypasses 31:13

1M ago31:13

31:13

Episode 73: In this episode of Critical Thinking - Bug Bounty Podcast we give a brief recap of Nahamcon and then touch on some topics like WAF bypass tools, sandboxed iframes, and programs redacting your reports. Follow us on twitter at: @ctbbpodcast We're new to this podcasting thing, so feel free to send us any feedback here: info@criticalthinkin…

1
Evolving Our View of the Coagulation Cascade and Stroke Management

2M ago

—

CME credits: 0.25 Valid until: 30-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/evolving-our-view-of-the-coagulation-cascade-and-stroke-management/24144/ How can you improve long-term secondary stroke prevention in patients with a history of noncardioembolic ischemic stroke or transient ischemic attack (TIA)? An understanding of…

1
Consensus Recommendations for Use of p16/Ki67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV

2M ago

—

CME credits: 0.25 Valid until: 29-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/consensus-recommendations-for-use-of-p16ki67-dual-staining-cytology-in-the-management-of-individuals-testing-positive-for-hpv/14675/ More effective triage tests are essential to improving cervical cancer risk-stratification and thus reducing the pote…

1
Episode 72: Research TLDRs & Smuggling Payloads in Well Known Data Types 52:49

2M ago52:49

52:49

Episode 72: In this episode of Critical Thinking - Bug Bounty Podcast Justin and Joel discuss some hot research from the past couple months. This includes ways to smuggle payloads in phone numbers and IPv6 Addresses, the NextJS SSRF, the PDF.JS PoC drop, and a GitHub Enterprise Indirect Method Information bug. Also, we have an attack vector feature…

1
Strategic Excellence: Mastering the Expanding ATTR-CM Therapeutic Landscape in Pharmacy Practice

2M ago

—

CME credits: 0.25 Valid until: 22-05-2025 Claim your CME credit at https://reachmd.com/programs/cme/strategic-excellence-mastering-the-expanding-attr-cm-therapeutic-landscape-in-pharmacy-practice/18124/ Join us in this educational endeavor to empower pharmacists with the latest insights and strategies for improved decision-making in ATTR-CM managem…

1
The State and Future of EO, with Sid Dixit (Space Exec, Former Maxar) 55:34

2M ago55:34

55:34

This week on Pathfinder, we're joined by Sid Dixit, former CTO of Maxar and a seasoned leader in the space industry. Sid's career spans pivotal roles at Planet, Amazon, and Maxar, where he has been at the forefront of satellite technology, artificial intelligence, and geospatial data platforms. Our discussion delves into the transformative impact o…

1
Episode 71: More VDP Chats & AI Bias Bounty Strats with Keith Hoodlet 1:45:21

2M ago1:45:21

1:45:21

Episode 71: In this episode of Critical Thinking - Bug Bounty Podcast Keith Hoodlet joins us to weigh in on the VDP Debate. He shares some of his insights on when VDPs are appropriate in a company's security posture, and the challenges of securing large organizations. Then we switch gears and talk about AI bias bounties, where Keith explains the ap…

1
Accurate Staging and Determining Resectability in NSCLC

2M ago

—

CME credits: 1.00 Valid until: 25-06-2025 Claim your CME credit at https://reachmd.com/programs/cme/accurate-staging-and-determining-resectability-in-nsclc/24385/ In this video series, learners will explore best practices for the use of immunotherapies in unresectable stage III NSCLC, including staging, determining resectability, applying clinical …

Podcasts Worth a Listen

Payload Podcasts

Podcasts Worth a Listen

Quick Reference Guide